SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-196671
Filing Date
2022-07-19
Accepted
2022-07-19 08:53:02
Documents
14
Period of Report
2022-07-18
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d382508d8k.htm   iXBRL 8-K 31379
2 EX-99.1 d382508dex991.htm EX-99.1 11342
6 GRAPHIC g382508g0719005148308.jpg GRAPHIC 4968
  Complete submission text file 0001193125-22-196671.txt   179104

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ino-20220718.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20220718_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20220718_pre.xml EX-101.PRE 11259
8 EXTRACTED XBRL INSTANCE DOCUMENT d382508d8k_htm.xml XML 3356
Mailing Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121
Business Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

IRS No.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 221090474
SIC: 3841 Surgical & Medical Instruments & Apparatus